Delisting Determination, The Nasdaq Stock Market, LLC, June 28, 2024,
Biophytis SA.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Biophytis SA, effective at the
opening of the trading session on July 8, 2024.
Based on review of information provided by the Company, Nasdaq Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rule 5550(b)(1).
The Company was notified of the Staff determination on October 26,
2023. On November 2, 2023, the Company exercised its right to appeal
the Staff determination to the Listing Qualifications Hearings Panel
(Panel) pursuant to Listing Rule 5815.
On February 7, 2024, upon review of the information provided by the
Company, the Panel determined to grant the Company request to remain
listed in the Exchange subject to a series of milestones (the Decision).
On April 5, 9, and 16, 2024, in response to requests by the Company,
the Panel amended the terms of the Decision.
On April 24, 2024, based on the Company failure to meet the terms
of the amended Decision, the Panel determined to delist the Company.
The Company securities were suspended on April 26, 2024.
The Company did not appeal the delist decision to the Nasdaq Listing
and Hearing Review Council (Council) and the Council did not call
the matter for review. The Staff determination to delist the Company
became final on June 10, 2024.